Copper-Catalyzed N-Arylation of Sulfoximines with Arylboronic Acids under Mild Conditions

Surabhi Gupta; Siddharth Baranwal; Nalluchamy Muniyappan; Shahulhameed Sabiah; Jeyakumar Kandasamy

doi:10.1055/s-0037-1612216

Synthesis, Table of Contents

Synthesis 2019; 51(10): 2171-2182
DOI: 10.1055/s-0037-1612216

paper

Copper-Catalyzed N-Arylation of Sulfoximines with Arylboronic Acids under Mild Conditions

Authors

Surabhi Gupta

^aDepartment of Chemistry, Indian Institute of Technology (BHU), 221005 Varanasi, Uttar Pradesh, India Email: jeyakumar.chy@iitbhu.ac.in
Siddharth Baranwal

^aDepartment of Chemistry, Indian Institute of Technology (BHU), 221005 Varanasi, Uttar Pradesh, India Email: jeyakumar.chy@iitbhu.ac.in
Nalluchamy Muniyappan

^bDepartment of Chemistry, Pondicherry University, 605014 Pondicherry, India
Shahulhameed Sabiah

^bDepartment of Chemistry, Pondicherry University, 605014 Pondicherry, India
Jeyakumar Kandasamy *

^aDepartment of Chemistry, Indian Institute of Technology (BHU), 221005 Varanasi, Uttar Pradesh, India Email: jeyakumar.chy@iitbhu.ac.in

Abstract

Full Text

PDF Download All articles of this category

Key words

arylation - boronic acid - sulfoximine - catalysis - copper

Sulfoximines are mono-aza analogues of sulfones that have been of considerable interest in chemistry and biology.[1] It has been noticed that functionalization of sulfoximines at the nitrogen center displays interesting biological and chemical properties. In this context, N-arylsulfoximines have been explored as efficient chiral ligands in asymmetric catalysis.[2`] [b] [c] [d] [e] On the other hand, Gnamm et al. have recently reported that N-arylsulfoximines exhibit interesting physicochemical and in vitro properties that are significant for drug discovery.[1c] N-Arylation of sulfoximine can be achieved with numerous aryl donors[3] such as aryl halides,[4] arylboronic acids,[5] aryl sulfonates,[6] aryl siloxanes,[7] arynes,[8] diaryliodonium salt,[9] etc.,[10] in the presence of Cu, Pd, Fe, and Ni catalysts.

Among them, Bolm’s copper-mediated Chan–Lam[11] coupling of sulfoximine with arylboronic acids was found to be more advantageous from a synthetic perspective.[5] This is because the N-arylation takes place at room temperature in the presence of catalytic amount of copper(II) acetate under mild reaction conditions. Moreover, arylboronic acids are cheap and more accessible and can be easily stored and handled. Despite having many advantages, this method also has some limitations. For example, N-arylation of sulfoximine failed with sterically hindered 2,4,6-trimethylphenylboronic acid. Moreover, this method also requires excess amount of arylboronic acids and longer reaction time.

It is well known that the nitrogen atom in the sulfoximine possesses poor nucleophilicity when compared with alkyl secondary amines,[12] which usually necessitates different reaction conditions for different N-functionalization reactions. In this context, we have envisioned that optimizing the reaction conditions with different copper salts in the presence of ligands/bases might lead to delightful results with respect to sterically hindered arylboronic acids. In continuation of our previous work on sulfoximine chemistry,[13] here we disclose an efficient method for the N-arylation of sulfoximines with sterically hindered arylboronic acids in the presence of copper(I) iodide and 4-DMAP at room temperature.

At the outset, optimization of the reaction conditions was investigated with S-methyl-S-phenylsulfoximine (1a) and sterically hindered 2,4,6-trimethylphenylboronic acid (2a) in the presence of various copper(I) and copper(II) salts (10 mol%) in methanol (Table [1], entries 1–5). The desired product was not observed even after 24 hours at room temperature with Cu(OAc)₂, CuSO₄, CuCl, CuBr, and CuI. It is well known that ligands and bases play an important role in cross-coupling reactions particularly if the substrates are poorly reactive or sterically hindered.[14] Recently, Phukan and co-workers disclosed the reaction of copper(I) iodide with 4-DMAP, which provides Cu[(DMAP)₄I]I complex in DMSO.[14e] This complex shows excellent catalytic activity in Chan–Lam reactions.[14e] In fact, we have recently demonstrated N-alkylation of sulfoximines with alkylboronic acids in the presence of copper(II) acetate and pyridine.[13] In light of this, N-arylation was performed with copper(II) acetate in the presence of pyridine as well as 4-DMAP in methanol. To our delight, the N-arylation proceeded smoothly, and N-(2,4,6-trimethyl)phenyl-S-methyl-S-phenylsulfoximine (3aa) was obtained in 59% and 77% yield, respectively (entries 6 and 7).

Table 1 Optimization of the Reaction Conditions^a

Entry	Catalyst (10 mol%)	Base (1 equiv)	Time (h)	Yield (%)^b
1	Cu(OAc)₂	–	24	n.r
2	CuSO₄	–	24	n.r
3	CuCl	–	24	n.r
4	CuBr	–	24	n.r
5	CuI	–	24	n.r
6	Cu(OAc)₂	Py	12	59
7	Cu(OAc)₂	4-DMAP	12	77
8	Cu(OAc)₂	DABCO	12	n.r
9	Cu(OAc)₂	DBU	12	n.r
10	Cu(OAc)₂	Et₃N	12	∼7
11	Cu(OAc)₂	2,2′-bipy	12	n.r
12	Cu(OAc)₂	K₂CO₃	12	n.r
13	CuSO₄	4-DMAP	12	20
14	CuCl	4-DMAP	12	60
15	CuBr	4-DMAP	12	69
16	CuI	4-DMAP	4	89
17	NiCl₂·6H₂O	4-DMAP	12	n.r
18	Ni(OAc)₂·4H₂O	4-DMAP	12	n.r
19	NiCl₂·6H₂O	2,2′-bipy/DBU	12	n.r^c
20	Ni(OAc)₂·4H₂O	DBU	12	n.r^d

^a Reaction conditions: 1a (155 mg, 1.0 mmol), 2a (1.5 equiv), copper salt (0.1 equiv), and base (1.0 equiv) were stirred in MeOH (2 mL) under open air.

^b Isolated yield; n.r. = no reaction.

^c Reaction was carried out in MeCN.

^d Reaction was carried out in DMSO.

The reaction was further investigated with various organic and inorganic bases such as DABCO, DBU, Et₃N, 2,2′-bipyridine and K₂CO₃ (Table [1], entries 8–12). Unfortunately, reactions did not proceed well with these additives. Hence, optimization was further investigated with different copper salts in the presence of 4-DMAP in methanol at room temperature (entries 13–16). Among all, copper(I) iodide/4-DMAP system gave the desired product 3aa in high yield (89%) within 4 hours under open air (entry 16). Furthermore, N-arylation was investigated with nickel salts such as NiCl₂ and Ni(OAc)₂ in the presence of different additives, which was previously explored in Chan–Lam coupling reactions (entries 17–20).[15] These reactions did not provide the desired product even after 12 hours at room temperature.

Having established the optimized conditions, N-arylation of different sulfoximines with 2,4,6-trimethylphenylboronic acid (2a) was investigated (Scheme [1]). To our delight, the substrates bearing linear and branched alkyl chains underwent N-arylation smoothly and provided the desired products 3ba and 3ca in 85–87% yields. It is worth noting that the sterically hindered S-isopropyl-S-phenylsulfoximine also participated in the coupling reaction with equal efficiency (Scheme [1], 3ca). Moreover, the substitutions on the aryl ring of the sulfoximine (electron-donating or -withdrawing) did not affect the progress of the reaction significantly (3da–fa). Encouraged, we further attempted the N-arylation of S,S-diphenyl, S-benzyl-S-phenyl, S,S-dibenzyl, and S,S-dialkyl sulfoximines as well as heterocyclic sulfoximine with 2,4,6-trimethylphenylboronic acid. To our delight, all these substrates underwent N-arylation smoothly in 71–92% yields (3ga–ka). Likewise, other sterically hindered ortho-substituted arylboronic acids such as 2,6-dimethyl- and 2,6-dimethoxyphenylboronic acids also gave N-arylated products 3ab and 3ac in 84% and 81% yield, respectively, in 3–4 hours.

Scheme 1 N-Arylation of sulfoximine 1a using sterically hindered arylboronic acids. Reagents and conditions: Sulfoximine (150 mg, 1 equiv), arylboronic acid (1.5 equiv), CuI (0.1 equiv), and DMAP (1.0 equiv) were stirred in MeOH (2 mL) under open air. Isolated yields are shown. For 3ac, arylboronic acid (2.4 equiv) and CuI (0.2 equiv) were used.

Further, we have investigated the N-arylation of different sulfoximines with sterically less hindered arylboronic acids (Scheme [2]). 4-Methylphenylboronic acid was chosen as a common aryl donor and was employed in the coupling reaction with a variety of sulfoximines under optimized conditions. To our delight, all these reactions proceeded smoothly with excellent yields within 2 hours (Scheme [2], 3ad–nd).

Scheme 2 N-Arylation of various sulfoximines using 4-methylphenylboronic acid. Reagents and conditions: Sulfoximine (150 mg, 1 equiv), 4-methylphenylboronic acid (1.5 equiv), CuI (0.1 equiv), and 4-DMAP (1.0 equiv) were stirred in MeOH (2 mL) under open air. Isolated yields are shown.

Having explored the substrate scope with different sulfoximines, N-arylation with different boronic acids was investigated (Scheme [3]). In this context, S-methyl-S-phenylsulfoximine (1a) was subjected to the coupling reaction with arylboronic acids bearing different functional groups under optimized conditions and the results are summarized in Scheme [3]. Arylboronic acids having electron-donating (e.g., Et, OMe, and SMe) and -withdrawing groups (F, Cl, Br, and NO₂) at the para or meta positions were successfully coupled with sulfoximine 1a in 78–91% yields (Scheme [3], 3ae–an). Further, to investigate the versatility of the developed methodology, arylboronic acids bearing sensitive functional groups such as vinyl, formyl, acyl, and nitrile were employed for N-arylation reactions. To our delight, the coupling reactions preceded smoothly, giving 40–82% yields under optimized reaction conditions (3ao–ar). Likewise, more conjugated arylboronic acids such as naphthyl- and biphenylboronic acids also participated in coupling reaction efficiently (3as–au). Similarly, N-arylation of dialkylsulfoximines was achieved in excellent yields (3me and 3mk).

Scheme 3 N-Arylation of S-methyl-S-phenylsulfoximine (1a) using various arylboronic acids. Reagents and conditions: Sulfoximine (150 mg, 1 equiv), arylboronic acid (1.5 equiv), CuI (0.1 equiv), and 4-DMAP (1.0 equiv) were stirred in MeOH (2 mL) at RT under open air. Isolated yields are shown.

Methionine sulfoximine (MSO) is a biologically relevant sulfoximine that plays an important role in drug discovery.[16] It is noteworthy that so far no method has been developed for the N-arylation of methionine sulfoximine. In this context, protected l-methionine sulfoximine was subjected to N-arylation with simple as well as sterically hindered arylboronic acids (Scheme [4]). To our delight, N-arylated l-methionine sulfoximines were obtained in 78–91% yield under optimized conditions (Scheme [4, 4a–d]), which reveals a great versatility of the developed protocol.

Scheme 4 N-Arylation of bioactive l-methionine sulfoximine with arylboronic acids. Reagents and conditions: Sulfoximine (150 mg, 1 equiv), arylboronic acid (1.5 equiv), CuI (0.018 g, 0.1 equiv), DMAP (0.118 g, 1.0 equiv), and MeOH (2 mL) were stirred at RT under open air. Isolated yields are shown. For 4b, arylboronic acid (2.4 equiv) and CuI (0.2 equiv) were used.

Scheme 5 N-Arylation with phenylboronic acid surrogates

It is also noteworthy that the arylboronic acid surrogates such as phenylboronic acid pinacol ester and potassium phenyltrifluoroborate also participated in the coupling reaction efficiently (Scheme [5]). Further, we have attempted to prepare the N-vinylsulfoximines[17] using vinylboronic acid. In this context, the optimized reaction conditions were well suited to the task with N-vinyl-S-methyl-S-phenylsulfoximine being obtained in 84% yield within 45 minutes at room temperature (Scheme [6], 3av).

Scheme 6 N-Vinylation with vinylboronic acid 2v

The mechanism of Chan–Lam coupling reaction is well documented in the literature. However, the role of 4-DMAP in the N-arylation of sulfoximine with sterically hindered arylboronic acid is not clear to us. Based on the previous reports,[14] a plausible mechanism has been proposed for N-arylation of sulfoximine using arylboronic acids (Scheme [7]). First, CuI and 4-DMAP provides Cu(II)-complex in situ under open air.[14e] This Cu(II) complex undergoes ligand exchange with sulfoximine to give the intermediate A. Subsequently, arylboronic acid undergoes trans-metalation with the complex A and forms the intermediate B. Finally, the reductive elimination of B provides the desired N-arylated product and copper(0) species. Under open air, the reduced Cu(0) catalyst was re-oxidized to Cu(II) species and the catalytic cycle is resumed.

Scheme 7 Proposed mechanism for N-arylation of sulfoximine with arylboronic acid

In conclusion, N-arylation of sulfoximines with arylboronic acid was demonstrated using a catalytic amount of copper(I) iodide and 4-DMAP in methanol at room temperature. A wide range of aryl, alkyl, diaryl, arylbenzyl, dibenzyl, and dialkyl sulfoximines were N-arylated with sterically hindered arylboronic acids as well as library of other substituted arylboronic acids. All reactions took place at room temperature and provided good to excellent yields of N-arylsulfoximines in a short span of time. For the first time, we have also demonstrated the N-arylation of biologically relevant l-methionine sulfoximine with different arylboronic acids at room temperature. Surprisingly, the optimized reaction was well suited to the task of N-arylation of sulfoximine with arylboronic acid surrogates and N-vinylation of sulfoximine with trans-2-phenylvinylboronic acid. Overall, the current methodology appears to be more general from a synthetic point of view, and thereby promises to find wide applications in organic synthesis.

Starting materials were prepared using either literature procedures or modified literature procedures.[18] Boronic acids were purchased from Aldrich and Alfa Aesar chemicals. All reactions were performed in round-bottomed flasks under open air. Solvents and other chemicals were purchased from commercial sources and used without further purification. TLC was performed using pre-coated plates contained from E. Merck (TLC silica gel 60 F254). TLC plates were visualized by exposure to ultraviolet light (UV), and then further analyzed by using an I₂ chamber or ninhydrin strain. Column chromatography (cc) was performed on silica gel (60–120 mesh) using an EtOAc/hexane mixture as eluent. ¹H and ¹³C NMR spectra were recorded on a Bruker Avance 500 MHz NMR spectrometer and mass spectra were measured on a Waters Quattro Micro V 4.1.

N-Arylation of Sulfoximines with Arylboronic Acids; General Procedure

A mixture of the respective sulfoximine (150 mg, 1 equiv, for 3aa, 3ba, 3ja, 3ab, 3ac, 3ad-3nd, 3ae-3au, 3me and 3mk) or (200 mg, 1 equiv, for 3ca-3ia and 3ka), CuI (10 mol%), and 4-DMAP (1 equiv) was stirred in MeOH (2 mL) under open air at RT for 5 min. The appropriate arylboronic acid or arylboronic acid surrogate or vinylboronic acid (1.5 equiv) was added to the reaction mixture and allowed to stir at RT. The progress of reaction was monitored by TLC. After completion, the reaction mixture was diluted with CH₂Cl₂ and washed with distilled water, aq NaHCO₃, and brine. The organic layer was dried (anhyd Na₂SO₄), filtered, and evaporated on a rotary evaporator. The crude product was purified by silica gel column chromatography using EtOAc/hexane as an eluent to obtain the desired products.

N-(2,4,6-Trimethylphenyl)-S,S-methylphenylsulfoximine (3aa)

Yield: 235 mg (89%); pale yellow oil; cc: 20% EtOAc/hexane; R_f = 0.25.

IR (KBr, film): 1449, 1232, 1221, 749 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.14 (d, J = 7.9 Hz, 2 H_arom), 7.59 (m, 3 H_arom), 6.84 (s, 2 H_arom), 3.02 (s, 3 H, CH₃), 2.33 (s, 6 H, 2 × CH₃), 2.23 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 141.4, 138.0, 133.9, 133.1, 132.5, 129.3, 129.2, 128.0, 43.3, 20.8, 20.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₆H₂₀NOS: 274.1226; found: 274.1257.

N-(2,4,6-Trimethylphenyl)-S,S-heptylphenylsulfoximine (3ba)

Yield: 199 mg (87%); transparent liquid; cc: 10% EtOAc/hexane; R_f = 0.28.

IR (KBr, film): 3280, 2936, 1454, 1218, 1123, 991, 754, 688 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.02 (d, J = 7.8 Hz, 2 H_arom), 7.58 (m, 1 H_arom), 7.52 (t, J = 7.4 Hz, 2 H_arom), 6.78 (s, 2 H_arom), 3.30 (m, 1 H, CH₂), 3.05 (m, 1 H, CH₂), 2.30 (s, 6 H, 2 × CH₃), 2.20 (s, 3 H, CH₃), 1.77–1.63 (m, 2 H, CH₂), 1.58–1.44 (m, 1 H, CH₂), 1.23–1.13 (m, 6 H, 3 × CH₂, 1 H, CH₂), 0.83–0.78 (m, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 140.2, 138.3, 133.7, 132.9, 132.1, 129.2, 129.1, 128.6, 56.4, 31.6, 28.8, 28.4, 23.8, 22.6, 20.8, 20.4, 14.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₂H₃₂NOS: 358.2199; found: 358.2195.

N-(2,4,6-Trimethylphenyl)-S,S-isopropylphenylsulfoximine (3ca)

Yield: 279 mg (85%); transparent liquid; cc: 10% EtOAc/hexane; R_f = 0.29.

IR (KBr, film): 3024, 2926, 1519, 1279, 1258, 1087, 1069, 1033 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.86 (d, J = 7.8 Hz, 2 H_arom), 7.57–7.41 (m, 3 H_arom), 6.72 (s, 2 H_arom), 3.53–3.42 (m, 1 H, CH), 2.25 (s, 6 H, 2 × CH₃), 2.16 (s, 3 H, CH₃), 1.42 (d, J = 6.8 Hz, 3 H, CH₃), 1.19 (d, J = 6.7 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 139.0, 138.9, 132.9, 132.7, 131.4, 129.2, 129.18, 129.12, 58.3, 20.8, 20.7, 17.4, 16.0.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₈H₂₄NOS: 302.1573; found: 302.1576.

N-(2,4,6-Trimethylphenyl)-S,S-ethyl(4-methoxyphenyl)sulfoximine (3da)

Yield: 286 mg (90%); transparent oil; cc: 20% EtOAc/hexane; R_f = 0.24.

IR (KBr, film): 3025, 2929, 1517, 1296, 1178, 1058, 1031, 1024, 990, 764 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.93 (d, J = 8.6 Hz, 2 H_arom), 6.98 (d, J = 8.8 Hz, 2 H_arom), 6.78 (s, 2 H_arom), 3.85 (s, 3 H, CH₃), 3.29 (m, 1 H, CH₂), 3.04 (m, 1 H, CH₂), 2.31 (s, 6 H, 2 × CH₃), 2.19 (s, 3 H, CH₃), 1.17 (t, J = 7.3 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 163.3, 138.6, 133.7, 132.0, 131.0, 130.7, 129.1, 114.4, 55.8, 50.8, 20.8, 20.4, 8.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₈H₂₄NO₂S: 318.1522; found: 318.1523.

N-(2,4,6-Trimethylphenyl)-S,S-(4-bromophenyl)methylsulfoximine (3ea)

Yield: 264 mg (88%); transparent oil; cc: 10% EtOAc/hexane; R_f = 0.25.

IR (KBr, film): 3036, 2928, 1586, 1474, 1289, 1214, 1181, 1093, 1033 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.98 (d, J = 8.5 Hz, 2 H_arom), 7.68 (d, J = 8.5 Hz, 2 H_arom), 6.82 (s, 2 H_arom), 3.02 (s, 3 H, CH₃), 2.29 (s, 6 H, 2 × CH₃), 2.22 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 140.6, 137.8, 133.8, 132.7, 132.6, 129.7, 129.3, 128.3, 43.6, 20.8, 20.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₆H₁₉BrNOS: 352.0365; found: 352.0367.

N-(2,4,6-Trimethylphenyl)-S,S-methyl(4-nitrophenyl)sulfoximine (3fa)

Yield: 276 mg (87%); yellow oil; cc: 5–10% EtOAc/hexane; R_f = 0.32.

IR (KBr, film): 3088, 3022, 2998, 2912, 1696, 1518, 1352, 1289, 1098, 1057 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.39 (d, J = 8.9 Hz, 2 H_arom), 8.29 (d, J = 8.9 Hz, 2 H_arom), 6.82 (s, 2 H_arom), 3.12 (s, 3 H, CH₃), 2.27 (s, 6 H, 2 × CH₃), 2.22 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 150.6, 148.2, 137.2, 133.6, 133.1, 129.4, 127.1, 124.6, 43.80, 20.8, 20.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₆H₁₉N₂O₃S: 319.1111; found: 319.1111.

N-(2,4,6-Trimethylphenyl)-S,S-diphenylsulfoximine (3ga)

Yield: 259 mg (84%); transparent oil; cc: 10% EtOAc/hexane; R_f = 0.31.

IR (KBr, film): 3089, 2913, 2874, 2380, 2342, 1461, 1274, 1218, 1138, 1109, 1091, 954, 746 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.94–7.88 (m, 4 H_arom), 7.49–7.48 (m, 2 H_arom), 7.45–7.40 (m, 4 H_arom), 6.72 (s, 2 H_arom), 2.20 (s, 6 H, 2 × CH₃), 2.16 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.4, 137.9, 133.7, 132.4, 132.1, 129.15, 129.10, 128.1, 20.82, 20.5.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₁H₂₂NOS: 336.1417; found: 336.1419.

N-(2,4,6-Trimethylphenyl)-S,S-benzylphenylsulfoximine (3ha)

Yield: 260 mg (81%); transparent oil; cc: 5% EtOAc/hexane; R_f = 0.24.

IR (KBr, film): 3053, 2914, 2838, 2352, 2334, 1445, 1286, 1219, 1134, 1123, 1086, 961, 741 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.80 (d, J = 7.4 Hz, 2 H_arom), 7.56 (t, J = 7.6 Hz, 1 H_arom), 7.43 (t, J = 7.9 Hz, 2 H_arom), 7.22 (d, J = 7.0 Hz, 1 H_arom), 7.15 (t, J = 7.4 Hz, 2 H_arom), 6.89 (d, J = 7.7 Hz, 2 H_arom), 6.84 (s, 2 H_arom), 4.48–4.16 (ABq, J = 13.5 Hz, 4 H, 2 × CH₂), 2.36 (s, 6 H, 2 × CH₃), 2.24 (s, 3 H, CH₃).

NMR (125 MHz, CDCl₃): δ = 138.6, 138.2, 133.9, 133.2, 132.4, 131.1, 129.7, 129.4, 129.3, 128.9, 128.43, 128.40, 62.8, 20.8, 20.5.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₂H₂₄NOS: 350.1573; found: 350.1567.

N-(2,4,6-Trimethylphenyl)-S,S-dibenzylsulfoximine (3ia)

Yield: 274 mg (82%); white solid; mp 131 °C; cc: 5% EtOAc/hexane; R_f = 0.26.

IR (KBr, film): 3274, 3111, 3058, 3012, 2986, 2976, 1514, 1445, 1418, 1232, 1125, 1071, 1067, 761, 691, 585 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.34 (s, 10 H_arom), 6.76 (s, 2 H_arom), 4.25–4.17 (ABq, J = 12.5 Hz, 4 H, 2 × CH₂), 2.19 (s, 3 H, CH₃), 2.07 (s, 6 H, 2 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 138.1, 134.0, 132.5, 131.5, 129.3, 129.1, 128.8, 58.5, 20.8, 19.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₃H₂₆NOS: 364.1730; found: 364.1732.

N-(2,4,6-Trimethylphenyl)-S,S-dibutylsulfoximine (3ja)

Yield: 177 mg (71%); pale yellow viscous oil; cc: 10% EtOAc/hexane; R_f = 0.34.

IR (KBr, film): 3272, 2960, 1724, 1466, 1380, 1242, 1101, 1016, 807, 729 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 6.79 (s, 2 H), 3.07–2.97 (m, 4 H), 2.27 (s, 6 H), 2.20 (s, 3 H), 1.84–1.78 (m, 4 H), 1.43–1.39 (m, 4 H), 0.92 (t, J = 7.3 Hz, 6 H).

¹³C NMR (125 MHz, CDCl₃): δ = 138.6, 133.8, 132.1, 129.0, 52.9, 25.7, 22.1, 20.8, 19.9, 13.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₇H₃₀NOS: 296.2048; found: 296.2078.

N-(2,4,6-Trimethylphenyl)-S,S-ethyl(2-pyridyl)sulfoximine (3ka)

Yield: 311 mg (92%); transparent liquid; cc: 10% EtOAc/hexane; R_f = 0.30.

IR (KBr, film): 3353, 3034, 2888, 2779, 2364, 2028, 1574, 1477, 1378, 1259, 1181, 1094, 983, 814 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.64 (d, J = 4.5 Hz, 1 H_arom), 7.78 (d, J = 7.8 Hz, 1 H_arom), 7.73 (t, J = 7.6 Hz, 1 H_arom), 7.37 (dd, J = 7.4, 4.8 Hz, 1 H_arom), 6.68 (s, 2 H_arom), 3.85 (m, 1 H, CH₂), 3.63 (m, 1 H, CH₂), 2.14 (s, 3 H, CH₃), 2.08 (s, 6 H, 2 × CH₃), 1.37 (t, J = 7.3 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 158.7, 149.7, 137.8, 137.6, 134.0, 132.1, 128.7, 126.3, 122.3, 46.7, 20.7, 19.5, 7.3.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₆H₂₁N₂OS: 289.1369; found: 289.1366.

N-(2,6-Dimethylphenyl)-S,S-methylphenylsulfoximine (3ab)

Yield: 210 mg (84%); yellow oil; cc: 20% EtOAc/hexane; R_f = 0.48.

IR (KBr, film): 1474, 1272, 1089, 756, 733 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.14 (d, J = 7.5 Hz, 2 H_arom), 7.59 (m, 3 H_arom), 7.01 (d, J = 7.4 Hz, 2 H_arom), 6.87 (t, J = 7.4 Hz, 1 H_arom), 3.03 (s, 3 H, CH₃), 2.36 (s, 6 H, 2 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 141.4, 140.9, 134.2, 133.2, 129.4, 128.4, 128.0, 123.3, 43.6, 20.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₈NOS: 260.1104; found: 260.1093.

N-(2,6-Dimethoxyphenyl)-S,S-methylphenylsulfoximine (3ac)

Yield: 228 mg (81%); yellow oil; cc: 40% EtOAc/hexane; R_f = 0.38.

IR (KBr, film): 1449, 1284, 1079, 765 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.08 (d, J = 7.7 Hz, 2 H_arom), 7.52 (m, 3 H_arom), 6.87 (t, J = 8.3 Hz, 1 H_arom), 6.51 (d, J = 8.3 Hz, 2 H_arom), 3.70 (s, 6 H, 2 × CH₃), 3.15 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 154.4, 143.1, 132.5, 129.1, 127.9, 122.6, 122.5, 105.2, 56.1, 45.9.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₉NO₃S: 292.1002; found: 292.0991.

N-(4-Methylphenyl)-S,S-methylphenylsulfoximine (3ad)

Yield: 215 mg (91%); white solid; mp 112–114 °C; cc: 30% EtOAc/hexane; R_f = 0.18.

IR (KBr, film): 3020, 2923, 1498, 1504, 1287, 1263, 1091, 1069, 1034 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.95 (d, J = 7.8 Hz, 2 H_arom), 7.52 (m, 3 H_arom), 6.90 (s, 4 H_arom), 3.20 (s, 3 H, CH₃), 2.18 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.3, 139.6, 133.3, 131.2, 129.7, 129.6, 128.8, 123.3, 46.0, 20.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₆NOS: 246.0953; found: 246.0940.

N-(4-Methylphenyl)-S,S-ethylphenylsulfoximine (3bd)

Yield: 230 mg (92%); brown solid; mp 86 °C; cc: 30% EtOAc/hexane; R_f = 0.24.

IR (KBr, film): 3369, 3057, 2929, 2786, 2359, 2048, 1594, 1487, 1394, 1265, 1193, 1093 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.89 (d, J = 7.9 Hz, 2 H_arom), 7.52 (m, 3 H_arom), 6.90 (s, 4 H_arom), 3.30 (m, 2 H, CH₂), 2.18 (s, 3 H, CH₃), 1.27 (t, J = 7.4 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.5, 137.6, 133.2, 130.9, 129.7, 129.6, 129.5, 123.3, 51.9, 20.8, 7.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₈NOS: 260.1109; found: 260.1102.

N-(4-Methylphenyl)-S,S-phenylpropylsulfoximine (3cd)

Yield: 243 mg (92%); white solid; mp 110 °C; cc: 30% EtOAc/hexane; R_f = 0.22.

IR (KBr, film): 3020, 2923, 1505, 1287, 1263, 1094, 1069, 1034 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.89 (d, J = 7.6 Hz, 2 H_arom), 7.51 (m, 3 H_arom), 6.89 (s, 4 H_arom), 3.28 (m, 1 H, CH₂), 3.23–3.16 (m, 1 H, CH₂), 2.17 (s, 3 H, CH₃), 1.76 (m, 2 H, CH₂), 0.95 (t, J = 7.4 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.5, 140.6, 138.3, 133.2, 130.8, 129.7, 129.5, 123.3, 59.2, 20.8, 16.7, 12.9.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₆H₂₀NOS: 274.1266; found: 274.1283.

N-(4-Methylphenyl)-S,S-isopropylphenylsulfoximine (3dd)

Yield: 230 mg (87%); pale yellow oil; cc: 20% EtOAc/hexane; R_f = 0.34.

IR (KBr, film): 3020, 2923, 1505, 1287, 1263, 1094, 1069, 1034 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.84 (d, J = 7.5 Hz, 2 H_arom), 7.54 (t, J = 7.2 Hz, 1 H_arom), 7.47 (t, J = 7.4 Hz, 2 H_arom), 6.89 (s, 4 H_arom), 3.39 (m, 1 H, CH), 2.17 (s, 3 H, CH₃), 1.40 (d, J = 6.6 Hz, 3 H, CH₃), 1.26 (d, J = 6.6 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.9, 136.2, 133.1, 130.58, 130.55, 129.6, 129.3, 123.2, 57.0, 20.8, 16.4, 15.9.

HRMS (ESI-TOF): m/z [M + Na]⁺ calcd for C₁₆H₁₉NOSNa: 296.1085; found: 296.1097.

N-(4-Methylphenyl)-S,S-heptylphenylsulfoximine (3ed)

Yield: 186 mg (90%); white solid; mp 76 °C; cc: 10% EtOAc/hexane; R_f = 0.50.

IR (KBr, film): 3272, 2927, 1445, 1223, 1110, 991, 752, 689 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.90 (d, J = 7.1 Hz, 2 H_arom), 7.54–7.46 (m, 3 H_arom), 6.90 (s, 4 H_arom), 3.34–3.28 (m, 1 H, CH₂), 3.24–3.18 (m, 1 H, CH₂), 2.17 (s, 3 H, CH₃), 1.79–1.78 (m, 1 H, CH₂), 1.67–1.65 (m, 1 H, CH₂), 1.33–1.15 (m, 8 H, 4 × CH₂), 0.83 (t, J = 6.8 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.5, 138.3, 133.1, 130.8, 130.1, 129.6, 129.52, 129.50, 123.3, 115.4, 57.6, 31.5, 28.8, 28.2, 22.8, 22.6, 20.8, 14.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₃NOS: 330.1886; found: 330.1889.

N-(4-Methylphenyl)-S,S-(4-methylphenyl)methylsulfoximine (3fd)

Yield: 204 mg (89%); pale yellow viscous oil; cc: 20% EtOAc/hexane; R_f = 0.40.

IR (KBr, film): 3021, 2922, 1505, 1288, 1197, 1093, 1033, 1013 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.82 (d, J = 8.1 Hz, 2 H_arom), 7.28 (d, J = 7.9 Hz, 2 H_arom), 6.90 (s, 4 H_arom), 3.18 (s, 3 H, CH₃), 2.38 (s, 3 H, CH₃), 2.18 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 144.1, 142.5, 136.6, 131.0, 130.3, 129.7, 128.8, 123.3, 46.2, 21.7, 20.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₈NOS: 260.1109; found: 260.1149.

N-(4-Methylphenyl)-S,S-(4-bromophenyl)methylsulfoximine (3gd)

Yield: 191 mg (92%); white solid; mp 150 °C; cc: 30% EtOAc/hexane; R_f = 0.36.

IR (KBr, film): 3026, 2926, 1588, 1486, 1288, 1201, 1094, 1030 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.80 (d, J = 8.3 Hz, 2 H_arom), 7.62 (d, J = 8.3 Hz, 2 H_arom), 6.91 (d, J = 8.1 Hz, 2 H_arom), 6.87 (d, J = 8.0 Hz, 2 H_arom), 3.20 (s, 3 H, CH₃), 2.19 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 141.9, 138.6, 132.9, 131.5, 130.4, 129.8, 128.6, 123.3, 46.1, 20.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₅BrNOS: 324.0058; found: 324.0056.

N-(4-Methylphenyl)-S,S-methyl-(4-nitrophenyl)sulfoximine (3hd)

Yield: 198 mg (91%); yellow solid; mp 85 °C; cc: 20% EtOAc/hexane; R_f = 0.28.

IR (KBr, film): 3094, 3029, 2932, 1529, 1348, 1294, 1089, 1041 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.33 (d, J = 8.5 Hz, 2 H_arom), 8.13 (d, J = 8.5 Hz, 2 H_arom), 6.92 (d, J = 8.1 Hz, 2 H_arom), 6.86 (d, J = 8.0 Hz, 2 H_arom), 3.27 (s, 3 H, CH₃), 2.18 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 150.7, 145.9, 141.3, 132.1, 130.3, 130.0, 124.8, 123.4, 45.8, 20.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₅N₂O₃S: 291.0803; found: 291.0804.

N-(4-Methylphenyl)-S,S-diphenylsulfoximine (3id)

Yield: 178 mg (84%); white solid; mp 171 °C; cc: 20% EtOAc/hexane; R_f = 0.52.

IR (KBr, film): 3083, 2905, 2877, 2381, 2341, 1467, 1286, 1208, 1119, 1104, 1093, 748 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.04 (d, J = 7.6 Hz, 4 H_arom), 7.50–7.41 (m, 6 H_arom), 7.04 (d, J = 8.0 Hz, 2 H_arom), 6.93 (d, J = 7.9 Hz, 2 H_arom), 2.19 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.0, 141.1, 132.7, 131.1, 129.7, 129.4, 128.7, 123.7, 20.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₉H₁₈NOS: 308.1109; found: 308.1100.

N-(4-Methylphenyl)-S,S-benzylphenylsulfoximine (3jd)

Yield: 173 mg (83%); pale yellow solid; mp 148–151 °C; cc: 20% EtOAc/hexane; R_f = 0.46.

IR (KBr, film): 3054, 2917, 2847, 2364, 2333, 1454, 1298, 1218, 1136, 1101, 1096 743 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.60 (d, J = 7.9 Hz, 2 H_arom), 7.49 (t, J = 7.4 Hz, 1 H_arom), 7.35 (t, J = 7.6 Hz, 2 H_arom), 7.26 (t, J = 7.4 Hz, 1 H_arom), 7.18 (t, J = 7.5 Hz, 2 H_arom), 6.99–6.91 (m, 6 H_arom), 4.51 (ABq, J = 13.7 Hz, 2 H, CH₂), 2.20 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.5, 136.7, 133.2, 131.4, 131.0, 129.9, 129.8, 129.0, 128.8, 128.6, 128.4, 123.4, 63.3, 20.8.

HRMS (ESI-TOF): m/z [M + Na]⁺ calcd for C₂₀H₁₉NOSNa: 344.1085; found: 344.1070.

N-(4-Methylphenyl)-S,S-dibenzylsulfoximine (3kd)

Yield: 169 mg (81%); pale yellow solid; mp 86 °C; cc: 20% EtOAc/hexane; R_f = 0.44.

IR (KBr, film): 3275, 3105, 3062, 3010, 2996, 2908, 1504, 1438, 1406, 1242, 1116, 1063, 1037, 760, 698, 580 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.34 (d, J = 6.2 Hz, 10 H_arom), 7.02–6.96 (m, 4 H_arom), 4.31–4.25 (ABq, J = 14.0 Hz, 4 H, 2 × CH₂), 2.26 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.7, 131.4, 129.9, 129.0, 128.9, 128.7, 123.4, 120.8, 57.5, 20.9.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₁H₂₂NOS: 336.1422; found: 336.1408.

N-(4-Methylphenyl)-S,S-ethyl(2-pyridyl)sulfoximine (3ld)

Yield: 213 mg (93%); pale yellow solid; mp 165 °C; cc: 20–30% EtOAc/hexane; R_f = 0.46.

IR (KBr, film): 3364, 3047, 2898, 2781, 2354, 2038, 1589, 1483, 1388, 1261, 1184, 1091,973, 814, 757 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.70 (d, J = 4.2 Hz, 1 H_arom), 8.08 (d, J = 7.8 Hz, 1 H_arom), 7.84 (t, J = 7.7 Hz, 1 H_arom), 7.45–7.40 (m, 1 H_arom), 6.94–6.86 (m, 4 H_arom), 3.65 (dq, J = 14.7, 7.4 Hz, 1 H, CH₂), 3.55 (dq, J = 14.7, 7.5 Hz, 1 H, CH₂), 2.17 (s, 3 H, CH₃), 1.28 (t, J = 7.4 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 156.6, 150.5, 142.1, 137.9, 131.3, 129.6, 126.8, 124.6, 123.5, 47.9, 20.8, 7.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₇N₂OS: 261.1062; found: 261.1073.

N-(4-Methylphenyl)-S,S-dibutylsulfoximine (3md)

Yield: 205 mg (91%); transparent oil; cc: 10% EtOAc/hexane; R_f = 0.38.

IR (KBr, film): 3272, 3018, 2940, 1724, 1486, 1380, 1242, 1101, 1071, 1036, 807, 729 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 6.99 (d, J = 8.3 Hz, 2 H_arom), 6.95 (d, J = 8.3 Hz, 2 H_arom), 3.17–3.03 (m, 4 H, 2 × CH₂), 2.25 (s, 3 H, CH₃), 1.82–1.76 (m, 4 H, 2 × CH₂), 1.44–1.36 (m, 4 H, 2 × CH₂), 0.83 (t, J = 7.4 Hz, 6 H, 2 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.8, 131.2, 129.8, 123.6, 51.7, 25.3, 21.9, 20.9, 13.8.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₂₆NOS: 268.1735; found: 268.1755.

N-(4-Methylphenyl)-S,S-cyclohexylheptylsulfoximine (3nd)

Yield: 170 mg (83%); yellow oil; cc: 15% EtOAc/hexane; R_f = 0.24.

IR (KBr, film): 3310, 2920, 2875, 2814, 2313, 1981, 1504, 1644, 1450, 1277, 1129, 1094, 1034, 958, 849, 773, 690 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 6.97 (s, 4 H_arom), 3.10–3.04 (m, 2 H, CH₂), 3.02–2.96 (m, 1 H, CH₂), 2.33–2.15 (m, 1 H, CH₂, 2 H, CH₂), 2.24 (s, 3 H, CH₃), 1.91–1.89 (m, 2 H, CH₂), 1.81–1.75 (m, 2 H, CH₂), 1.69 (d, J = 12.2 Hz, 1 H, CH₂), 1.64–1.48 (m, 2 H, CH₂), 1.33–1.23 (m, 10 H, 5 × CH₂), 0.84 (t, J = 6.8 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 143.3, 130.9, 130.1, 129.7, 123.6, 115.3, 61.7, 48.8, 31.6, 28.9, 28.7, 26.4, 26.0, 25.7, 25.6, 25.3, 22.8, 22.7, 20.9, 14.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₀H₃₅NOS: 336.2356; found: 336.2351.

N-Phenyl-S,S-methylphenylsulfoximine (3ae)

Yield: 203 mg (91%); white solid; mp 100–101 °C; cc: 30% EtOAc/hexane; R_f = 0.22.

IR (KBr, film): 3044, 2089, 1614, 1486, 1267, 1202, 1093, 1040 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.94–7.88 (m, 2 H_arom), 7.48 (m, 3 H_arom), 7.05 (t, J = 7.8 Hz, 2 H_arom), 6.94 (d, J = 7.5 Hz, 2 H_arom), 6.80 (t, J = 7.3 Hz, 1 H_arom), 3.17 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 145.1, 139.7, 133.4, 129.7, 129.2, 128.8, 123.5, 121.9, 46.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₄NOS: 232.0796; found: 232.0778.

N-(4-Ethylphenyl)-S,S-methylphenylsulfoximine (3af)

Yield: 225 mg (90%); pale yellow oil; cc: 30% EtOAc/hexane; R_f = 0.28.

IR (KBr, film): 3299, 1615, 1517, 1286, 1225, 1090, 1010, 833 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.96 (d, J = 7.7 Hz, 2 H_arom), 7.53 (m, 3 H_arom), 6.94 (d, J = 8.4 Hz, 2 H_arom), 6.91 (d, J = 8.4 Hz, 2 H_arom), 3.20 (s, 3 H), 2.49 (q, J = 7.5 Hz, 2 H, CH₂), 1.12 (t, J = 7.6 Hz, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 142.4, 139.7, 137.6, 133.3, 129.6, 128.8, 128.5, 123.3, 46.1, 28.2, 15.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₈NOS: 260.1109; found: 260.1100.

N-(4-Methoxyphenyl)-S,S-methylphenylsulfoximine (3ag)

Yield: 229 mg (91%); white solid; mp 102–106 °C; cc: 40% EtOAc/hexane; R_f = 0.18.

IR (KBr, film): 3012, 2930, 2833, 1513, 1444, 1263, 1239, 1042 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.99–7.90 (m, 2 H_arom), 7.58–7.47 (m, 3 H_arom), 6.93 (d, J = 9.0 Hz, 2 H_arom), 6.66 (d, J = 9.0 Hz, 2 H_arom), 3.67 (s, 3 H, CH₃), 3.19 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 155.0, 139.7, 138.1, 133.3, 129.6, 128.9, 124.5, 114.5, 55.5, 45.8.

HRMS (ESI-TOF): m/z [M+ H]⁺ calcd for C₁₄H₁₆NO₂S: 262.0902; found: 262.0887.

N-(4-Thiomethylphenyl)-S,S-methylphenylsulfoximine (3ah)

Yield: 209 mg (78%); yellow oil; cc: 20% EtOAc/hexane; R_f = 0.42.

IR (KBr, film): 3012, 2930, 2833, 1513, 1444, 1263, 1239, 1042 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.93 (d, J = 7.8 Hz, 2 H_arom), 7.56 (t, J = 7.2 Hz, 1 H_arom), 7.50 (t, J = 7.6 Hz, 2 H_arom), 7.04 (d, J = 8.4 Hz, 2 H_arom), 6.92 (d, J = 8.4 Hz, 2 H_arom), 3.21 (s, 3 H, CH₃), 2.35 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 143.1, 139.3, 133.4, 130.1, 129.7, 128.9, 128.7, 123.9, 46.1, 17.3.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₆NOS₂: 278.0673; found: 278.0693.

N-(4-Fluorophenyl)-S,S-methylphenylsulfoximine (3ai)

Yield: 207 mg (86%); white solid; mp 82–86 °C; cc: 40% EtOAc/hexane; R_f = 0.28.

IR (KBr, film): 3053, 3002, 2928, 1445, 1281, 1263, 1208, 1093, 1032, 821, 745, 679 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.87 (d, J = 7.7 Hz, 2 H_arom), 7.48 (m, 3 H_arom), 6.88 (d, J = 8.7, 2 H_arom), 6.72 (d, J = 8.7 Hz, 2 H_arom), 3.15 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 158.3 (d, J _C,F = 239.0), 141.0 (d, J _C,F = 2.6), 139.1, 133.3, 129.6, 128.6, 124.4 (d, J _C,F = 7.7 Hz), 115.5 (d, J _C,F = 22.1 Hz), 46.0.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₃FNOS: 250.0702; found: 250.0687.

N-(4-Chlorophenyl)-S,S-methylphenylsulfoximine (3aj)

Yield: 226 mg (88%); white solid; mp 64–66 °C; cc: 40% EtOAc/hexane; R_f = 0.38.

IR (KBr, film): 3064, 3014, 2926, 1487, 1402, 1371, 1291, 1198, 1091, 738, 681 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.91 (d, J = 7.9 Hz, 2 H_arom), 7.56 (t, J = 7.3 Hz, 1 H_arom), 7.49 (t, J = 7.6 Hz, 2 H_arom), 7.02 (d, J = 8.6 Hz, 2 H_arom), 6.90 (d, J = 8.6 Hz, 2 H_arom), 3.20 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 143.8, 139.0, 133.5, 129.7, 129.0, 128.7, 126.8, 124.5, 46.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₃ClNOS: 266.0406; found: 266.0396.

N-(4-Bromophenyl)-S,S-methylphenylsulfoximine (3ak)

Yield: 266 mg (89%); white solid; mp 109–111 °C; cc: 30% EtOAc/hexane; R_f = 0.44.

IR (KBr, film): 3109, 3026, 2926, 1485, 1401, 1267, 1203, 1007, 821, 732 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.91 (d, J = 7.9 Hz, 2 H_arom), 7.53 (m, 3 H_arom), 7.17 (d, J = 8.2 Hz, 2 H_arom), 6.85 (d, J = 8.2 Hz, 2 H_arom), 3.21 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 144.4, 138.9, 133.6, 132.0, 129.7, 128.7, 124.9, 114.4, 46.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₃BrNOS: 309.9901; found: 309.9896.

N-(4-Nitrophenyl)-S,S-methylphenylsulfoximine (3al)

Yield: 221 mg (83%); yellow solid; mp 149–150 °C; cc: 40% EtOAc/hexane; R_f = 0.22.

IR (KBr, film): 3097, 3020, 2913, 1592, 1294, 1050, 1013 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.95 (d, J = 8.7 Hz, 2 H_arom), 7.91 (d, J = 7.9 Hz, 2 H_arom), 7.61 (t, J = 7.3 Hz, 1 H_arom), 7.53 (t, J = 7.6 Hz, 2 H_arom), 6.97 (d, J = 8.7 Hz, 2 H_arom), 3.29 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 162.3, 152.8, 141.7, 138.2, 134.1, 130.0, 128.5, 126.3, 125.3, 122.5, 115.8, 46.6.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₃N₂O₃S: 277.0647; found: 277.0637.

N-(3,5-Dichlorophenyl)-S,S-methylphenylsulfoximine (3am)

Yield: 249 mg (86%); white solid; mp 83 °C; cc: 30% EtOAc/hexane; R_f = 0.40.

IR (KBr, film): 3109, 3026, 2926, 1485, 1401 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.91 (d, J = 7.8 Hz, 2 H_arom), 7.62–7.51 (m, 3 H_arom), 6.87 (s, 2 H_arom), 6.81 (s, 1 H_arom), 3.22 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 147.5, 138.5, 134.9, 133.9, 129.9, 128.6, 121.8, 121.6, 46.3.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₃H₁₂Cl₂NOS: 300.0017; found: 300.0011.

N-(3-Trifluoromethylphenyl)-S,S-methylphenylsulfoximine (3an)

Yield: 254 mg (88%); pale yellow oil; cc: 30% EtOAc/hexane; R_f = 0.28.

IR (KBr, film): 3129, 3016, 2936, 1486, 1401 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.98 (d, J = 7.8 Hz, 2 H_arom), 7.63 (t, J = 7.3 Hz, 1 H_arom), 7.56 (t, J = 7.5 Hz, 2 H_arom), 7.28 (d, J = 2.9 Hz, 1 H_arom), 7.24–7.09 (m, 3 H_arom), 3.28 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 145.8, 138.9, 133.7, 131.4 (q, J _C,F = 32 Hz), 129.8, 129.5, 128.7, 126.1, 124.2 (q, J _C,F = 272.5 Hz), 120.2 (q, J = 3.7 Hz), 118.3 (q, J = 3.9 Hz), 46.3.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₃F₃NOS: 300.0670; found: 300.0656.

N-(4-Vinylphenyl)-S,S-methylphenylsulfoximine (3ao)

Yield: 203 mg (82%); pale yellow oil; cc: 30% EtOAc/hexane; R_f = 0.16.

IR (KBr, film): 3022, 2910, 2833, 1622, 1513, 1263, 1239, 1042 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.94 (d, J = 7.8 Hz, 2 H_arom), 7.53 (dt, J = 32.7, 7.5 Hz, 3 H_arom), 7.16 (d, J = 8.3 Hz, 2 H_arom), 6.95 (d, J = 8.3 Hz, 2 H_arom), 6.55 (dd, J = 17.6, 10.9 Hz, 1 H, CH), 5.53 (d, J = 17.6 Hz, 1 H, CH₂), 5.04 (d, J = 10.9 Hz, 1 H, CH₂), 3.22 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 145.0, 139.4, 136.6, 133.4, 131.2, 129.7, 128.7, 127.1, 123.3, 111.6, 46.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₆NOS: 258.0953; found: 258.0958.

N-(4-Formylphenyl)-S,S-methylphenylsulfoximine (3ap)

Yield: 151 mg (60%); pale yellow solid; mp 92–94 °C; cc: 40% EtOAc/hexane; R_f = 0.38.

IR (KBr, film): 3001, 2921, 2836, 1688, 1595 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 9.75 (s, 1 H_arom), 7.93 (d, J = 7.8 Hz, 2 H_arom), 7.60 (t, J = 6.9 Hz, 3 H_arom), 7.53 (t, J = 7.7 Hz, 2 H_arom), 7.05 (d, J = 8.4 Hz, 2 H_arom), 3.28 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 191.3, 152.2, 138.7, 133.9, 131.4, 130.2, 130.0, 128.6, 123.0, 116.1, 46.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₄NO₂S: 260.0745; found: 260.0736.

N-(4-Acetylphenyl)-S,S-methylphenylsulfoximine (3aq)

Yield: 119 mg (45%); brown solid; mp 86–87 °C; cc: 40% EtOAc/hexane; R_f = 0.22.

IR (KBr, film): 3001, 2911, 2836, 1725, 1597 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.92 (d, J = 7.7 Hz, 2 H_arom), 7.71 (d, J = 8.5 Hz, 2 H_arom), 7.59 (t, J = 7.3 Hz, 1 H_arom), 7.52 (t, J = 7.6 Hz, 2 H_arom), 6.98 (d, J = 8.5 Hz, 2 H_arom), 3.26 (s, 3 H, CH₃), 2.45 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 197.3, 150.7, 138.8, 133.8, 130.7, 130.0, 129.9, 128.6, 122.6, 46.6, 26.4.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₆NO₂S: 274.0902; found: 274.0892.

N-(4-Cyanophenyl)-S,S-methylphenylsulfoximine (3ar)

Yield: 99 mg (40%); pale yellow oil; cc: 40% EtOAc/hexane; R_f = 0.24.

IR (KBr, film): 3030, 2930, 2217, 1601, 1490, 1298 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.91 (d, J = 7.9 Hz, 2 H_arom), 7.62 (t, J = 7.4 Hz, 1 H_arom), 7.55 (d, J = 7.6 Hz, 2 H_arom), 7.35 (d, J = 8.3 Hz, 2 H_arom), 6.98 (d, J = 8.3 Hz, 2 H_arom), 3.27 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 150.3, 138.5, 134.0, 133.4, 130.0, 128.6, 123.3, 119.8, 104.1, 46.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₁₃N₂OS: 257.0749; found: 257.0737.

N-(1-naphthyl)-S,S-methylphenylsulfoximine (3as)

Yield: 231 mg (85%); brown oil; cc: 30% EtOAc/hexane; R_f = 0.22.

IR (KBr, film): 3065, 3019, 2923, 1511, 1481, 1282, 1191, 1059 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 8.54 (d, J = 8.2 Hz, 1 H_arom), 7.99 (d, J = 7.9 Hz, 2 H_arom), 7.74 (d, J = 7.9 Hz, 1 H_arom), 7.56–7.44 (m, 5 H_arom), 7.37 (d, J = 8.1 Hz, 1 H_arom), 7.16 (t, J = 7.8 Hz, 1 H_arom), 7.08 (d, J = 7.4 Hz, 1 H_arom), 3.32 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 141.7, 139.4, 134.7, 133.4, 130.2, 129.7, 128.6, 127.9, 126.2, 126.0, 125.2, 124.1, 121.7, 116.6, 46.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₇H₁₆NOS: 282.0953; found: 282.0942.

N-(2-Naphthyl)-S,S-methylphenylsulfoximine (3at)

Yield: 231 mg (85%); brown solid; mp 91–92 °C; cc: 30% EtOAc/hexane; R_f = 0.26.

IR (KBr, film): 3012, 2930, 1521, 1499, 1316, 1298, 1246, 1080, 1013 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.85 (d, J = 7.2 Hz, 2 H_arom), 7.54–7.31 (m, 6 H_arom), 7.24 (s, 1 H_arom), 7.17 (t, J = 6.9 Hz, 1 H_arom), 7.10 (d, J = 7.7 Hz, 2 H_arom), 3.12 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 143.0, 139.3, 134.5, 133.4, 129.7, 129.6, 128.86, 128.82, 127.5, 127.0, 126.0, 124.9, 123.8, 118.7, 46.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₇H₁₆NOS: 282.0953; found: 282.0940.

N-(4-Benzylphenyl)-S,S-methylphenylsulfoximine (3au)

Yield: 154 mg (52%); white solid; mp 140–141 °C; cc: 30% EtOAc/hexane; R_f = 0.14.

IR (KBr, film): 3015, 3019, 2923, 1599, 1511, 1481, 1281, 836 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.99 (d, J = 7.6 Hz, 2 H_arom), 7.58 (t, J = 7.3 Hz, 1 H_arom), 7.54–7.47 (m, 4 H_arom), 7.38–7.33 (m, 4 H_arom), 7.24 (t, J = 7.3 Hz, 1 H_arom), 7.07 (d, J = 8.4 Hz, 2 H_arom), 3.24 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 144.6, 141.0, 139.5, 134.5, 133.4, 129.7, 128.7, 127.8, 126.7, 123.6, 46.2.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₉H₁₈NOS: 308.1109; found: 308.1103.

N-Phenylethynyl-S,S-methylphenylsulfoximine (3av)

Yield: 209 mg (84%); brown oil; cc: 30% EtOAc/hexane; R_f = 0.36.

IR (KBr, film): 1698, 1636, 1217, 1096, 983, 739, 695 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.94 (d, J = 7.3 Hz, 2 H_arom), 7.63 (t, J = 6.9 Hz, 1 H_arom), 7.57 (t, J = 7.3 Hz, 2 H_arom), 7.16 (m, 4 H_arom), 7.04 (m, 1 H_arom), 6.90 (d, J = 13.6 Hz, 1 H_arom), 6.19 (d, J = 13.6 Hz, 1 H_arom), 3.20 (s, 3 H, CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 139.4, 138.0, 133.7, 129.9, 129.8, 128.8, 128.5, 125.7, 125.1, 118.3, 45.5.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₅H₁₆NOS: 258.0953; found: 258.0930.

N-Phenyl-S,S-dibutylsulfoximine (3me)

Yield: 197 mg (92%); yellow viscous oil; cc: 10% EtOAc/hexane; R_f = 0.42.

IR (KBr, film): 3048, 2097, 1624, 1573, 1479, 1319, 1274, 1201, 1160, 1079, 943, 841 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.18 (t, J = 7.8 Hz, 2 H_arom), 7.06 (d, J = 7.4 Hz, 2 H_arom), 6.91 (t, J = 7.3 Hz, 1 H_arom), 3.17–3.06 (m, 4 H, 2 × CH₂), 1.83–1.76 (m, 4 H, 2 × CH₂), 1.43–1.37 (m, 4 H, 2 × CH₂), 0.91 (t, J = 7.3 Hz, 6 H, 2 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 145.7, 129.2, 123.6, 121.8, 51.8, 25.2, 21.8, 13.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₂₄NOS: 254.1579; found: 254.1571.

N-(4-Bromophenyl)-S,S-dibutylsulfoximine (3mk)

Yield: 250 mg (89%); pale yellow oil; cc: 40% EtOAc/hexane; R_f = 0.38.

IR (KBr, film): 3272, 3020, 2960, 1726, 1476, 1381, 1262, 1101, 1056, 1002, 807, 729 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.26 (d, J = 8.7 Hz, 2 H_arom), 6.93 (d, J = 8.7 Hz, 2 H_arom), 3.16–3.04 (m, 4 H, 2 × CH₂), 1.81–1.76 (m, 4 H, 2 × CH₂), 1.43–1.38 (m, 4 H, 2 × CH₂), 0.91 (t, J = 7.3 Hz, 6 H, 2 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 145.1, 132.1, 125.1, 114.4, 52.0, 25.1, 21.8, 13.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₄H₂₃BrNOS: 332.0684; found: 332.0664.

N-Arylation of an l-Methionine Sulfoximine Derivative with Arylboronic Acids; General Procedure

A mixture of L-methionine sulfoximine derivative (200 mg, 0.59 mmol), CuI (11 mg, 10 mol%), and 4-DMAP (72 mg, 0.59 mmol, 1 equiv) was stirred in MeOH (2 mL) at RT for 5 min under open air. Afterwards, the appropriate arylboronic acid (0.89 mmol, 1.5 equiv) was added and the reaction mixture was allowed to stir at RT until the completion of reaction. The progress of reaction was monitored by TLC using 20–40% EtOAc/hexane as eluent (ninhydrin stain). After completion, the mixture was filtered through a pad of Celite and washed with CH₂Cl₂, and the CH₂Cl₂ solution was evaporated on a rotary evaporator. The crude product was purified by silica gel column chromatography using 10–50% EtOAc/hexane as eluent to obtain the desired product.

tert-Butyl 2-[(tert-Butoxycarbonyl)amino]-4-(S-methyl-N-phenylsulfonimidoyl)butanoate (4a)

Yield: 223 mg (91%); transparent oil; cc: 40% EtOAc/hexane; product spot identified on TLC using ninhydrin stain; R_f = 0.18.

IR (KBr, film): 3845, 3322, 2941, 2817, 2641, 2320, 2082, 1717, 1610, 1529, 1486, 1233, 1202, 1088, 1047, 853, 744 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 7.19 (t, J = 6.9 Hz, 2 H_arom), 7.04 (t, J = 7.0 Hz, 2 H_arom), 6.94 (t, J = 7.2 Hz, 1 H_arom), 5.26 (s, 1 H, CH), 4.22 (s, 1 H, NH), 3.38–3.16 (m, 2 H, SCH₂), 3.03 (s, 3 H, SCH₃), 2.43–2.40 (m, 1 H, CH₂), 2.20–2.10 (m, 1 H, CH₂), 1.41 (d, J = 7.4 Hz, 18 H, 6 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 170.3, 155.5, 145.1, 145.0, 129.44, 129.42, 123.6, 123.5, 122.4, 83.2, 80.4, 52.8, 52.1, 51.1, 50.9, 39.8, 39.7, 28.4, 28.15, 28.11, 27.0.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₀H₃₄N₂O₅S: 413.2105; found: 413.2104.

tert-Butyl 2-[(tert-Butoxycarbonyl)amino]-4-[N-(2,6-dimethoxyphenyl)-S-methylsulfonimidoyl]butanoate (4b)

Yield: 219 mg (78%); transparent oil; cc: 40% EtOAc/hexane; product spot identified on TLC using ninhydrin stain; R_f = 0.24.

IR (KBr, film): 3842, 3321, 2976, 2941, 2837, 2641, 2320, 2082, 1717, 1529, 1446, 1271, 1223, 1148, 1087, 853, 766, 744 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 6.91 (t, J = 8.2 Hz, 1 H_arom), 6.54 (d, J = 8.2 Hz, 2 H_arom), 5.42–5.19 (m, 1 H, CH), 4.25 (s, 1 H, NH), 3.81 (s, 6 H, 2 × OCH₃), 3.32–3.22 (m, 2 H, SCH₂), 3.05 (d, J = 9.0 Hz, 3 H, SCH₃), 2.45 (d, J = 5.1 Hz, 1 H, CH₂), 2.27–2.22 (m, 1 H, CH₂), 1.43 (d, J = 8.2 Hz, 18 H, 6 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 170.9, 154.9, 123.1, 105.2, 105.1, 82.6, 80.1, 56.2, 53.0, 41.7, 29.9, 28.5, 28.4, 28.1.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₂H₃₈N₂O₇S: 473.2316; found: 473.2315.

tert-Butyl 2-[(tert-Butoxycarbonyl)amino]-4-(N-mesityl-S-methylsulfonimidoyl)butanoate (4c)

Yield: 213 mg (79%); transparent oil; cc: 30% EtOAc/hexane; product spot identified on TLC using ninhydrin stain; R_f = 0.24.

IR (KBr, film): 3845, 3322, 2941, 2817, 2641, 2320, 2082, 1717, 1529, 1446, 1223, 1148, 1047, 853, 744 cm^–1.

¹H NMR (500 MHz, CDCl₃): δ = 6.80 (s, 2 H_arom), 5.27–5.20 (m, 1 H, CH), 4.24 (s, 1 H, NH), 3.33–3.14 (m, 2 H, SCH₂), 2.89 (s, 3 H, SCH₃), 2.49–2.40 (m, 1 H, CH₂), 2.24 (s, 6 H, 2 × ArCH ₃-o), 2.20 (s, 3 H, ArCH ₃-p), 2.17–2.11 (m, 1 H, CH₂), 1.44–1.42 (m, 18 H, 6 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 170.6, 155.6, 138.1, 133.8, 133.7, 132.5, 129.16, 129.14, 83.1, 52.8, 52.3, 51.9, 40.08, 29.8, 28.4, 28.1, 27.4, 20.8, 19.7.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₃H₄₀N₂O₅S: 455.2574; found: 455.2576.

tert-Butyl (2S)-4-[N-(4-Bromophenyl)-S-methylsulfonimidoyl]-2-[(tert-butoxycarbonyl)amino]butanoate (4d)

Yield: 260 mg (89%); transparent liquid; cc: 40% EtOAc/hexane; product spot identified on TLC using ninhydrin stain; R_f = 0.20.

IR (KBr, film): 3845, 3322, 2981, 2856, 2641, 2320, 2082, 1717, 1529, 1476, 1263, 1201, 1142, 1047, 1004, 853, 744 cm^–1.

¹H NMR (500 MHz, CDCl3): δ = 7.28 (d, J = 7.5 Hz, 2 H_arom), 6.91 (d, J = 7.7 Hz, 2 H_arom), 5.26 (s, 1 H, CH), 4.21 (s, 1 H, NH), 3.33–3.17 (m, 2 H, SCH₂), 3.01 (s, 3 H, SCH₃), 2.40–2.35 (m, 1 H, CH₂), 2.13–2.06 (m, 1 H, CH₂), 1.42–1.40 (m, 18 H, 6 × CH₃).

¹³C NMR (125 MHz, CDCl₃): δ = 170.3, 155.5, 144.4, 144.3, 132.3, 132.2, 125.17, 125.14, 115.0, 83.2, 80.4, 52.6, 51.1, 50.9, 39.8, 39.7, 29.8, 28.4, 28.1, 28.0, 27.0.

HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₂₀H₃₃BrN₂O₅S: 491.1210; found: 419.1204.

References

References

1a Reggelin M, Zur C. Synthesis 2000; 1
1b Lucking U. Angew. Chem. Int. Ed. 2013; 52: 9399
1c Frings M, Bolm C, Blum A, Gnamm C. Eur. J. Med. Chem. 2017; 126: 225
1d Bizet V, Kowalczyk R, Bolm C. Chem. Soc. Rev. 2014; 43: 2426

2a Bolm C. Sulfoximines as Ligands in Asymmetric Metal Catalysis. In Asymmetric Synthesis with Chemical and Biological Methods. Enders D, Jaeger K.-E. Wiley-VCH; Weinheim: 2007
2b Remy P, Langner M, Bolm C. Org. Lett. 2006; 8: 1209
2c Langner M, Bolm C. Angew. Chem. Int. Ed. 2004; 43: 5984
2d Sedelmeier J, Hammerer T, Bolm C. Org. Lett. 2008; 10: 917
2e Frings M, Thome I, Bolm C. Beilstein J. Org. Chem. 2012; 8: 1443

3 Vessally E, Mohammadi R, Hosseinian A, Didehban K, Edjlali L. J. Sulfur Chem. 2018; 39: 674

4a Sedelmeier J, Bolm C. J. Org. Chem. 2005; 70: 6904
4b Bolm C, Hildebrand JP. J. Org. Chem. 2000; 65: 169
4c Cho GY, Remy P, Jansson J, Moessner C, Bolm C. Org. Lett. 2004; 6: 3293
4d Correa A, Bolm C. Adv. Synth. Catal. 2008; 350: 391
4e Yongpruksa N, Calkins NL, Harmata M. Chem. Commun. 2011; 47: 7665
4f Harmata M, Hong X, Ghosh SK. Tetrahedron Lett. 2004; 45: 5233

5 Moessner C, Bolm C. Org. Lett. 2005; 7: 2667

6a Bolm C, Hildebrand JP, Rudolph J. Synthesis 2000; 911
6b Yang Q, Choy PY, Zhao Q, Leung MP, Chan HS, So CM, Wong WT, Kwong FY. J. Org. Chem. 2018; 83: 11369

7 Kim J, Ok J, Kim S, Choi W, Lee PH. Org. Lett. 2014; 16: 4602
8 Aithagani SK, Dara S, Munagala G, Aruri H, Yadav M, Sharma S, Vishwakarma RA, Singh PP. Org. Lett. 2015; 17: 5547
9 Vaddula B, Leazer J, Varma RS. Adv. Synth. Catal. 2012; 354: 986

10a Wang L, Priebbenow DL, Dong W, Bolm C. Org. Lett. 2014; 16: 2661
10b Lämmermann H, Sudau A, Rackl D, Weinmann H, Collins K, Wortmann L, Candish L, Hog D, Meier R. Synlett 2018; 29: 2679

11a Chan DM. T, Monaco KL, Wang RP, Winters MP. Tetrahedron Lett. 1998; 39: 2933
11b Lam PY. S, Clark CG, Saubern S, Adams J, Winters MP, Chan DM. T, Combs A. Tetrahedron Lett. 1998; 39: 2941

12 Hendriks CM. M, Bohmann RA, Bohlem M, Bolm C. Adv. Synth. Catal. 2014; 356: 1847
13 Gupta S, Chaudhary P, Muniyappan N, Sabiah S, Kandasamy J. Org. Biomol. Chem. 2017; 15: 8493

14a Bedford RB, Hazelwood SL, Limmert ME, Brown JM, Ramdeehul S, Cowley AR, Coles SJ, Hursthouse MB. Organometallics 2003; 22: 1364
14b Surry DS, Buchwald SL. Chem. Sci. 2010; 1: 13
14c Bhunia S, Pawar GG, Kumar SV, Jiang YW, Ma DW. Angew. Chem. Int. Ed. 2017; 56: 16136
14d Hamann BC, Hartwig JF. J. Am. Chem. Soc. 1998; 120: 7369
14e Roy S, Sarma MJ, Kashyap B, Phukan P. Chem. Commun. 2016; 52: 1170
14f Vantourout JC, Law RP, Isidro-Llobet A, Atkinson SJ, Watson AJ. B. J. Org. Chem. 2016; 81: 3942

15a Raghuvanshi K, Zell D, Ackermann L. Org. Lett. 2017; 19: 1278
15b Kumar KA, Kannaboina P, Rao DN, Das P. Org. Biomol. Chem. 2016; 14: 8989

16a Brusilow WS. A, Peters TJ. Expert Opin. Ther. Targets 2017; 21: 461
16b Buglioni L, Bizet V, Bolm C. Adv. Synth. Catal. 2014; 356: 2209
16c Griffith OW. J. Biol. Chem. 1982; 257: 13704

17a Dehli JR, Bolm C. Adv. Synth. Catal. 2005; 347: 239
17b Hetzer RH, Gais HJ, Raabe G. Synthesis 2008; 1126
17c Ikeda M, Tsubouchi H, Tsunekawa M, Kondo H, Tamura Y. Chem. Pharm. Bull. 1984; 32: 3028

18a Zenzola M, Doran R, Degennaro L, Luisi R, Bull JA. Angew. Chem. Int. Ed. 2016; 55: 7203
18b Lohier J.-F, Glachet T, Marzag H, Gaumont A.-C, Reboul V. Chem. Commun. 2017; 53: 2064
18c Tota A, Zenzola M, Chawner SJ, St John-Campbell S, Carlucci C, Romanazzi G, Degennaro L, Bull JA, Luisi R. Chem. Commun. 2017; 53: 348

Figures